Planet Biotechnology Incorporated

Basic Information

25571 CLAWITER RD
HAYWARD , CA, 94545-2740

Company Profile

n/a

Additional Details

Field Value
DUNS: 052917593
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A MERS-CoV Receptor Decoy

    Amount: $801,833.00

    DESCRIPTION provided by applicant Middle East respiratory syndrome coronavirus MERS CoV is a newly emerging human health threat with a case fatality rate MERS CoV uses dipeptidyl peptidase ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Lab research for the development of anti-diphetheria antibodies in humans

    Amount: $150,000.00

    Diphtheria is an acute bacterial disease with a considerable case fatality rate caused by toxigenic Corynebacteria. Diphtheria toxin (DT) is the major virulence factor for these organisms. DT is synth ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Enhanced Recovery of Pharmaceutical Solvent driven by EPA Initiative

    Amount: $276,767.00

    DESCRIPTION (provided by applicant): Antibody-dependent cellular cytotoxicity (ADCC) is an important mechanism by which therapeutic monoclonal antibodies (mAbs) kill tumor cells. However, killing by ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. An immunoadhesin for treatment of hypercholesterolemia

    Amount: $282,629.00

    DESCRIPTION (provided by applicant): In this project we propose producing, and testing in vivo, a recombinant protein that should sustainably reduce plasma low-density lipoprotein cholesterol (LDL-C). ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Plant-Made Nanobodies for Botulism Treatment

    Amount: $236,847.00

    DESCRIPTION (provided by applicant): The ultimate goal of the research described in this application is to develop an economical, safe and effective therapeutic that can reverse the paralytic symptoms ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. Novel Therapy for Pulmonary Anthrax

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): Planet Biotechnology Inc. (PBI) is developing a therapeutic recombinant protein, PBI-220, that neutralizes anthrax toxin in vitro and protects against inhalationa ...

    SBIR Phase II 2010 Department of Health and Human Services
  7. Maximizing Expression of Immunoglobulins in Plants

    Amount: $797,961.00

    DESCRIPTION (provided by applicant): Planet Biotechnology Inc. (PBI) has pioneered methods for the production of functional therapeutic antibodies and immunoadhesins in transgenic tobacco. For rea ...

    SBIR Phase II 2010 Department of Health and Human Services
  8. An Immunoadhesin Therapy for Gastrointestinal Anthrax

    Amount: $159,096.00

    DESCRIPTION (provided by applicant): The development of anthrax countermeasures has focused almost exclusively on the perceived threat of inhalational anthrax. However, preparing a sufficiently fine p ...

    SBIR Phase I 2009 Department of Health and Human Services
  9. Improved Method for Purification of Therapeutic Proteins from Plants

    Amount: $109,964.00

    DESCRIPTION (provided by applicant): Transgenic plants are a promising platform for the large-scale production of antibodies and other therapeutic proteins for treating serious and life-threatening co ...

    SBIR Phase I 2008 Department of Health and Human Services
  10. An Anti-Cancer Immunoadhesin Made in Plants

    Amount: $159,450.00

    DESCRIPTION (provided by applicant): The growth and metastasis of tumors depends, to a large extent, on the development of new blood vessels to supply food and oxygen to rapidly growing and dividing c ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government